Two Sigma Investments, LP Arvinas, Inc. Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 178,326 shares of ARVN stock, worth $4.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

178,326

Previous 105,919 68.36%

Holding current value

$4.39 Million

Previous $4.37 Million 8.58%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $1.77 Million - $2.93 Million	72,407 Added 68.36%	178,326 $4.75 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $3.85 Million - $5.54 Million	105,919 New	105,919 $4.37 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $2.51 Million - $3.61 Million	-127,825 Reduced 78.52%	34,964 $686,000
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $431,362 - $623,916	19,851 Added 13.89%	162,789 $4.04 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $3.74 Million - $5.33 Million	142,938 New	142,938 $3.91 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $1.18 Million - $1.63 Million	28,135 New	28,135 $1.25 Million
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $2.7 Million - $3.66 Million	-44,813 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $12.8 Million - $18.7 Million	-194,819 Reduced 81.3%	44,813 $3.68 Million
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $2.22 Million - $3.28 Million	-30,370 Reduced 11.25%	239,632 $19.7 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $5.07 Million - $7.07 Million	83,885 Added 45.07%	270,002 $20.8 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $10.8 Million - $17 Million	186,117 New	186,117 $12.3 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $6.19 Million - $26 Million	-306,648 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $1.92 Million - $3.04 Million	83,697 Added 37.54%	306,648 $7.24 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $4.37 Million - $8.3 Million	146,210 Added 190.52%	222,951 $7.48 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $32,406 - $53,519	982 Added 1.3%	76,741 $3.09 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $858,608 - $2.48 Million	55,790 Added 279.38%	75,759 $3.11 Million
Q3 2019 Nov 14, 2019	BUY	$21.55 - $27.61 $430,331 - $551,344	19,969 New	19,969 $430,000

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

68.7M

Call Options Held

166K

Put Options Held

31.3K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.31B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Arvinas, Inc. Transaction History